It is estimated to reach $1.93 billion by 2029, growing at a compound annual growth ... Several leading businesses in the targeted alpha-therapy market are concentrating their efforts on creating ...

Early research suggests a brain test may predict whether antidepressants will cause sexual dysfunction. There has never been ...

Protagonist Therapeutics eyes a Johnson & Johnson buyout interest, with blockbuster drug potential and high acquisition hopes ...

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its oncology portfolio and pipeline will be ...

Lilly to present new clinical data for Verzenio and multiple novel pipeline programMEs at the 2025 ESMO annual meeting: Indianapolis Tuesday, October 14, 2025, 09:00 Hrs [IST] Eli ...

AbbVie (NYSE: ABBV) today announced it will unveil new data from its robust antibody-drug conjugate (ADC) platform at the 2025 European Society for Medical Oncology (ESMO) Congress, taking place ...